Author Reply to The Semaglutide Paradox in Non-Overweight Diabetes: A Benefit Without Explanation

Journal Article Accepted manuscript Author Reply to The Semaglutide Paradox in Non-Overweight Diabetes: A Benefit Without Explanation Get access Takefumi Kishimori , Takefumi Kishimori Department of Cardiovascular Medicine, Omi Medical Center, Kusatsu, Japan Search for other works by this author on: Oxford Academic Google Scholar Takao Kato Takao Kato Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan Corresponding author: Takao Kato, MD, PhD, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan, Phone: +81-75-751-3190; Fax: +81-75-751-3203; E-mail: [email protected] https://orcid.org/0000-0001-8213-7999 Search for other works by this author on: Oxford Academic Google Scholar European Heart Journal - Quality of Care and Clinical Outcomes, qcaf090, https://doi.org/10.1093/ehjqcco/qcaf090 Published: 18 August 2025 Article history Received: 05 August 2025 Accepted: 15 August 2025 Published: 18 August 2025